Physiologically refined cell culture conditions uncover oncogene-dependent metabolic signatures in Ewing sarcoma spheroids
A. Katharina CeranskiiD, Martha Julia Carreño-GonzaleziD, Anna C. EhlersiD, Kimberley M. HansseniD, Nadine Gmelin, Florian H. GeyeriD, Zuzanna Kolodynska, Endrit VincaiD, Tobias FaehlingiD, Philipp BiechliD, Shunya OhmuraiD, Florencia Cidre‐AranaziD, Almut SchulzeiD, Thomas G. P. GrünewaldiD
Abstract
Ewing sarcoma (EwS) cell line culture largely relies on standard techniques, which do not recapitulate physiological conditions. Here, we report on a physiologically improved, feasible, and cost-efficient EwS cell culture technique employing an advanced medium composition, reduced fetal calf serum, and spheroidal growth. Functional in vitro assays and transcriptome profiling demonstrated that these refined conditions better recapitulate proliferation rates of patient tumors as well as hypoxic conditions relevant for EwS pathophysiology. Moreover, transcriptional signatures associated with the oncogenic activity of the EwS-specific FET::ETS fusion transcription factors in the refined culture conditions were shifted from proliferative towards metabolic gene signatures. The herein presented optimized physiological EwS cell culture technique provides a broadly applicable approach for enhanced in vitro modeling relevant to advancing EwS research and the validity of experimental results. MOTIVATIONCell culture remains the main platform to model EwS for research purposes. Yet, concerns exist about the limitations of standard in vitro techniques to adequately reflect physiological conditions. In this study, we refined EwS cell culture methods to increase modeling capacity while ensuring a practical and cost-effective handling, thereby broadening their applicability within the scientific community.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 10
- FWCI
- 4.09
- Field percentile
- top 5%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
Martin F. Orth, Didier Surdez, … Thomas G. P. Grünewald·Cell ReportsPeer-reviewed·Dec 1, 2022
- Inhibition Of One-Carbon Metabolism In Ewing Sarcoma Results In Profound And Prolonged Growth Suppression Associated With Purine Depletion
Sara Zirpoli, Noah Copperman, … Antonio Di Cristofano·bioRxiv·Apr 13, 2025
- Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth
E. Vasileva, M. Warren, … J. F. Amatruda·bioRxiv·May 25, 2021
- Dynamic modelling of EWS::FLI1 fluctuations reveals molecular determinants of phenotypic tumor plasticity and prognosis in Ewing sarcoma
Veveeyan Suresh, Christoph Hafemeister, … Valerie Fock·bioRxiv·Apr 3, 2025
- Oncogenic hijacking of a developmental transcription factor evokes therapeutic vulnerability for ROS-induction in Ewing sarcoma
A. Marchetto, S. Ohmura, … T. G. P. Grunewald·bioRxiv·Mar 14, 2019
- Dynamic oncogene activity metabolically reprograms the tryptophan-kynurenine-AHR axis driving immune evasion and tumor progression in Ewing sarcoma
Martha Julia Carreño-Gonzalez, Kimberley M. Hanssen, … Thomas G. P. Grünewald·bioRxiv·May 16, 2025